Timothy Ko, CEO, Entheon Biomedical. Timothy Ko has a broad background of leading private ventures in the Service Sector, Investor Relations, Retail and Technology. Most recently he served as Director of Hyperbridge Technology, a company focused on the development of decentralized technologies that facilitate crowdfunding.
Timothy’s passion for the psychedelic space is shaped by firsthand knowledge of the shortcomings of the current mental health and substance-use treatment models, and through his exposure to psychedelics, which he credits with saving his life. Following the loss of a loved one to a decades’ long fight with mental health and addictions, and through his personal experiences, Timothy is driven to develop and commercialize the life saving potential of psychedelic medicines.